OraSure Technologies

Yahoo Finance • 12 days ago

OraSure to Participate in Upcoming Investor Conference

BETHLEHEM, Pa., Nov. 17, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference: Stephens Annual Investment Conference on Wedn... Full story

Yahoo Finance • 30 days ago

Validea Kenneth Fisher Strategy Daily Upgrade Report - 10/30/2025

The following are today's upgrades for Validea's Price/Sales Investor model based on the published strategy of Kenneth Fisher. This value strategy rewards stocks with low P/S ratios, long-term profit growth, strong free cash flow and consi... Full story

Yahoo Finance • last month

OraSure to Announce Third Quarter 2025 Financial Results and Host Earnings Call on November 5th

BETHLEHEM, Pa., Oct. 29, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2025 financial results and certain business developments for 5 p.m. ET... Full story

Yahoo Finance • last month

OraSure Technologies Appoints Steven K. Boyd to its Board of Directors

Seasoned Investor with Deep Experience in the Healthcare and Medical Device Industries Brings Valuable Capital Markets Expertise and Investor Perspective OraSure Board Has Added Three New Independent Directors in the Past Three Years Mar... Full story

Yahoo Finance • 3 months ago

Exclusive-Altai Capital lays groundwork for board fight at OraSure Technologies, sources say

By Svea Herbst-Bayliss NEW YORK (Reuters) -Altai Capital Management is preparing to launch a board fight at OraSure Technologies after the hedge fund, already one of the biggest owners of the medical device maker, increased its holdings,... Full story

Yahoo Finance • 4 months ago

OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition

Earnings Call Insights: OraSure Technologies (OSUR) Q2 2025 MANAGEMENT VIEW * CEO Carrie Eglinton Manner highlighted progress on OraSure’s three-pillar strategy: "strengthening our foundation; two, elevating our core growth; and three,... Full story

Yahoo Finance • 4 months ago

OraSure Appoints Anne Messing as Chief Commercial Officer

BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as... Full story

Yahoo Finance • 4 months ago

OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th

BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business developments for 5 p.m. ET... Full story

Yahoo Finance • 5 months ago

Orasure gets takeover bid proposal from Ron Zwanziger- Reuters

[The concept of the word M&A on cubes on a beautiful green background] Zhanna Hapanovich/iStock via Getty Images Healthcare entrepreneur Ron Zwanziger recently made an unsolicited offer to buy OraSure Technologies, a company known for its... Full story

Yahoo Finance • 5 months ago

OraSure Launches Blood Collection Tube For High-Quality Proteomic Research

(RTTNews) - OraSure Technologies, Inc. (OSUR), a leader in point-of-need diagnostics and sample management, has introduced the HEMAcollect PROTEIN blood collection tube - BCT to address the growing demands of proteomic researchers. Develo... Full story

Yahoo Finance • 5 months ago

OraSure Launches Novel Blood Collection Device for Proteomic Research

BETHLEHEM, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the launch of its HEMAcollect™●PROT... Full story

Yahoo Finance • 6 months ago

Evercore says 23andMe buyout removes downside case for OraSure

Evercore ISI believes Regeneron’s (REGN) acquisition of 23andMe for $256M announcement should remove the downside scenario where OraSure’s (OSUR) 23andMe contribution will be zero into perpetuity. Instead, the firm expects 23andMe should c... Full story

Yahoo Finance • 7 months ago

OraSure to Announce First Quarter 2025 Financial Results and Host Earnings Call on May 7th

BETHLEHEM, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2025 financial results and certain business developments for 5 p.m. ET... Full story

Yahoo Finance • 8 months ago

OraSure Announces $40 Million Stock Repurchase Program

BETHLEHEM, Pa., March 24, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that its Board of Director... Full story

Yahoo Finance • 9 months ago

OraSure to Announce Fourth Quarter 2024 Financial Results and Host Earnings Call on February 25th

BETHLEHEM, Pa., Feb. 14, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2024 financial results and certain business developments for 5 p.m. ET... Full story

Yahoo Finance • last year

OraSure Technologies Inc. (OSUR): Among the Most Profitable Penny Stocks to Invest In

We recently compiled a list of the 8 Most Profitable Penny Stocks To Invest In.In this article, we are going to take a look at where OraSure Technologies Inc. (NASDAQ:OSUR) stands against the other profitable penny stocks. Potential in Sm... Full story

Yahoo Finance • 2 years ago

OraSure to Participate in Upcoming Investor Conferences

BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today annou... Full story

Yahoo Finance • 2 years ago

Q3 2023 OraSure Technologies Inc Earnings Call

Participants Carrie Eglinton Manner; President, CEO & Director; OraSure Technologies, Inc. Jason Plagman Kenneth J. McGrath; CFO; OraSure Technologies, Inc. Andrew Harris Cooper; Research Analyst; Raymond James & Associates, Inc., Rese... Full story

Yahoo Finance • 2 years ago

OraSure Reports Q3 ‘23 Revenue of $89.2 Million; Core Revenue Grows 7% Year-over-Year

Q3 GAAP EPS of $0.15; Q3 Non-GAAP EPS of $0.27 Grew cash balance to $224.9 million as of September 30, 2023 BETHLEHEM, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home... Full story

Yahoo Finance • 2 years ago

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

BETHLEHEM, Pa., Oct. 23, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2023 financial results and certain business developments for 5:00 pm ET... Full story